U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907446) titled 'Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies' on March 10.
Brief Summary: To study a novel biopsy needle system for performing transperineal prostate biopsy. Prostate biopsy remains the standard approach for prostate cancer detection. While pre-biopsy MRI allows for targeting of visible lesions, systemic or 'off target' samples are recommended due to the well-recognized risk of undegrading and under sampling with current commercially available needles. The SureCore plus single-use biopsy needle produces a more intact tissue core with a same caliber 18g needle with ~21% more t...